Myofascial pain syndrome

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Myofascial pain syndrome (MPS) is a form of myalgia that is characterized by local regions of muscle hardness that are tender and that cause pain to be felt at a distance, i.e., referred pain. The central component of the syndrome is the trigger point that is composed of a tender, taut band. Stimulation of the band, either mechanically or with activity, can produce pain. The active trigger point has identifiable pathophysiologic changes. The concentrations of a number of substances are measurably elevated in the milieu of the active trigger point, namely substance P, CGRP, bradykinin, and assorted cytokines, indicating that there is a chemical inflammatory response. The pH of the trigger point milieu is low, about pH 5. This is in keeping with the findings that the trigger point is hypoxic and ischemic, and therefore acidic. The trigger point has a unique electromyographic feature of persistent, low-amplitude, high frequency discharges that look like endplate potentials. The taut band conducts energy faster than the surrounding muscle tissue does because it is stiffer. The taut band can also be visualized using high definition ultrasonograpy. Clinical diagnosis of a MPS is made by history and by palpation of muscle to identify the taut band. Predisposing and perpetuating factors such as iron insufficiency, vitamin D deficiency, and chronic pelvic pain are considered and addressed if found. The goal is to eliminate the trigger points, reverse trigger point-induced weakness and incoordination, and restore normal muscle function. Manual trigger point releases, and needling the trigger point, without or with local anesthetic, and use of low-level laser are effective ways of inactivating trigger points and reducing pain. MPSs can mimic or cause many common conditions such as chronic daily headache and pelvic pain because of the pain referral patterns of the trigger points.

Original languageEnglish (US)
Title of host publicationMuscle Pain
Subtitle of host publicationDiagnosis and Treatment
PublisherSpringer-Verlag Berlin Heidelberg
Pages15-83
Number of pages69
ISBN (Electronic)9783642054686
ISBN (Print)9783642054679
DOIs
StatePublished - Jan 1 2010

Fingerprint

Myofascial Pain Syndromes
Trigger Points
Pain
Muscles
Pelvic Pain
Referred Pain
Headache Disorders
Vitamin D Deficiency
Palpation
Myalgia
Hardness
Bradykinin
Ataxia
Substance P
Local Anesthetics
Chronic Pain
Causality

Keywords

  • Electromyography
  • Endplate potentials
  • Inactivation of trigger points
  • Iron insufficiency
  • Needling
  • Pain referral
  • Taut band
  • Trigger point
  • Ultrasonograpy
  • Vitamin D deficiency

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Gerwin, R. (2010). Myofascial pain syndrome. In Muscle Pain: Diagnosis and Treatment (pp. 15-83). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-05468-6_2

Myofascial pain syndrome. / Gerwin, Robert.

Muscle Pain: Diagnosis and Treatment. Springer-Verlag Berlin Heidelberg, 2010. p. 15-83.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gerwin, R 2010, Myofascial pain syndrome. in Muscle Pain: Diagnosis and Treatment. Springer-Verlag Berlin Heidelberg, pp. 15-83. https://doi.org/10.1007/978-3-642-05468-6_2
Gerwin R. Myofascial pain syndrome. In Muscle Pain: Diagnosis and Treatment. Springer-Verlag Berlin Heidelberg. 2010. p. 15-83 https://doi.org/10.1007/978-3-642-05468-6_2
Gerwin, Robert. / Myofascial pain syndrome. Muscle Pain: Diagnosis and Treatment. Springer-Verlag Berlin Heidelberg, 2010. pp. 15-83
@inbook{75b0f583b65b4fdc898551e9a5e4272d,
title = "Myofascial pain syndrome",
abstract = "Myofascial pain syndrome (MPS) is a form of myalgia that is characterized by local regions of muscle hardness that are tender and that cause pain to be felt at a distance, i.e., referred pain. The central component of the syndrome is the trigger point that is composed of a tender, taut band. Stimulation of the band, either mechanically or with activity, can produce pain. The active trigger point has identifiable pathophysiologic changes. The concentrations of a number of substances are measurably elevated in the milieu of the active trigger point, namely substance P, CGRP, bradykinin, and assorted cytokines, indicating that there is a chemical inflammatory response. The pH of the trigger point milieu is low, about pH 5. This is in keeping with the findings that the trigger point is hypoxic and ischemic, and therefore acidic. The trigger point has a unique electromyographic feature of persistent, low-amplitude, high frequency discharges that look like endplate potentials. The taut band conducts energy faster than the surrounding muscle tissue does because it is stiffer. The taut band can also be visualized using high definition ultrasonograpy. Clinical diagnosis of a MPS is made by history and by palpation of muscle to identify the taut band. Predisposing and perpetuating factors such as iron insufficiency, vitamin D deficiency, and chronic pelvic pain are considered and addressed if found. The goal is to eliminate the trigger points, reverse trigger point-induced weakness and incoordination, and restore normal muscle function. Manual trigger point releases, and needling the trigger point, without or with local anesthetic, and use of low-level laser are effective ways of inactivating trigger points and reducing pain. MPSs can mimic or cause many common conditions such as chronic daily headache and pelvic pain because of the pain referral patterns of the trigger points.",
keywords = "Electromyography, Endplate potentials, Inactivation of trigger points, Iron insufficiency, Needling, Pain referral, Taut band, Trigger point, Ultrasonograpy, Vitamin D deficiency",
author = "Robert Gerwin",
year = "2010",
month = "1",
day = "1",
doi = "10.1007/978-3-642-05468-6_2",
language = "English (US)",
isbn = "9783642054679",
pages = "15--83",
booktitle = "Muscle Pain",
publisher = "Springer-Verlag Berlin Heidelberg",

}

TY - CHAP

T1 - Myofascial pain syndrome

AU - Gerwin, Robert

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Myofascial pain syndrome (MPS) is a form of myalgia that is characterized by local regions of muscle hardness that are tender and that cause pain to be felt at a distance, i.e., referred pain. The central component of the syndrome is the trigger point that is composed of a tender, taut band. Stimulation of the band, either mechanically or with activity, can produce pain. The active trigger point has identifiable pathophysiologic changes. The concentrations of a number of substances are measurably elevated in the milieu of the active trigger point, namely substance P, CGRP, bradykinin, and assorted cytokines, indicating that there is a chemical inflammatory response. The pH of the trigger point milieu is low, about pH 5. This is in keeping with the findings that the trigger point is hypoxic and ischemic, and therefore acidic. The trigger point has a unique electromyographic feature of persistent, low-amplitude, high frequency discharges that look like endplate potentials. The taut band conducts energy faster than the surrounding muscle tissue does because it is stiffer. The taut band can also be visualized using high definition ultrasonograpy. Clinical diagnosis of a MPS is made by history and by palpation of muscle to identify the taut band. Predisposing and perpetuating factors such as iron insufficiency, vitamin D deficiency, and chronic pelvic pain are considered and addressed if found. The goal is to eliminate the trigger points, reverse trigger point-induced weakness and incoordination, and restore normal muscle function. Manual trigger point releases, and needling the trigger point, without or with local anesthetic, and use of low-level laser are effective ways of inactivating trigger points and reducing pain. MPSs can mimic or cause many common conditions such as chronic daily headache and pelvic pain because of the pain referral patterns of the trigger points.

AB - Myofascial pain syndrome (MPS) is a form of myalgia that is characterized by local regions of muscle hardness that are tender and that cause pain to be felt at a distance, i.e., referred pain. The central component of the syndrome is the trigger point that is composed of a tender, taut band. Stimulation of the band, either mechanically or with activity, can produce pain. The active trigger point has identifiable pathophysiologic changes. The concentrations of a number of substances are measurably elevated in the milieu of the active trigger point, namely substance P, CGRP, bradykinin, and assorted cytokines, indicating that there is a chemical inflammatory response. The pH of the trigger point milieu is low, about pH 5. This is in keeping with the findings that the trigger point is hypoxic and ischemic, and therefore acidic. The trigger point has a unique electromyographic feature of persistent, low-amplitude, high frequency discharges that look like endplate potentials. The taut band conducts energy faster than the surrounding muscle tissue does because it is stiffer. The taut band can also be visualized using high definition ultrasonograpy. Clinical diagnosis of a MPS is made by history and by palpation of muscle to identify the taut band. Predisposing and perpetuating factors such as iron insufficiency, vitamin D deficiency, and chronic pelvic pain are considered and addressed if found. The goal is to eliminate the trigger points, reverse trigger point-induced weakness and incoordination, and restore normal muscle function. Manual trigger point releases, and needling the trigger point, without or with local anesthetic, and use of low-level laser are effective ways of inactivating trigger points and reducing pain. MPSs can mimic or cause many common conditions such as chronic daily headache and pelvic pain because of the pain referral patterns of the trigger points.

KW - Electromyography

KW - Endplate potentials

KW - Inactivation of trigger points

KW - Iron insufficiency

KW - Needling

KW - Pain referral

KW - Taut band

KW - Trigger point

KW - Ultrasonograpy

KW - Vitamin D deficiency

UR - http://www.scopus.com/inward/record.url?scp=84920118910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920118910&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-05468-6_2

DO - 10.1007/978-3-642-05468-6_2

M3 - Chapter

AN - SCOPUS:84920118910

SN - 9783642054679

SP - 15

EP - 83

BT - Muscle Pain

PB - Springer-Verlag Berlin Heidelberg

ER -